Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Joyzyme GroupHKSE:08622 +3.13%40 Gross Margin % is 58.62% as of Dec. 2025, which is 13% below its 10-year median of 67.16. GuruFocus rates HKSE:08622 with a GF Score™ of 40/100 and a GF Value™ of HK$0.17 (Fairly Valued). The stock has 4 warning signs investors should review. Among 939 Drug Manufacturers companies, Joyzyme Group ranks better than 73.16% on this metric.
The historical rank and industry rank for Joyzyme Group's Gross Margin % or its related term are showing as below:
HKSE:08622'
s Gross Margin % Range Over the Past 10 Years
Min: 62.8 Med: 67.16 Max: 75.25
Current: 62.8
During the past 11 years, the highestGross Margin % of Joyzyme Group was 75.25%. The lowest was 62.80%. And the median was 67.16%.
HKSE:08622's Gross Margin % is ranked better than 73.16% of 939
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs HKSE:08622: 62.80
Joyzyme Group had a gross margin of 58.62% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Joyzyme Group was -0.40% per year.
Joyzyme Group (HKSE:08622) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Joyzyme Group had a gross margin of 58.62% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Joyzyme Group Gross Margin % Related Terms
Joyzyme Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for Joyzyme Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Joyzyme Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Joyzyme Group Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Joyzyme Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Joyzyme Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Joyzyme Group (HKSE:08622) has a Gross Margin % of 58.62% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Joyzyme Group and its competitors. This is 13% below median its historical median of 67.16. Over the past decade, Joyzyme Group's Gross Margin % has ranged from 62.80 to 75.25. According to the industry distribution chart, Joyzyme Group ranks #252 out of 939 companies in the Drug Manufacturers industry, placing it in the top 26.8%.
Is Joyzyme Group's Gross Margin % too high?
Joyzyme Group's current Gross Margin % of 58.62% is 13% below median its 10-year median of 67.16. Over the past 10 years, this metric has ranged from a low of 62.80 to a high of 75.25. The Drug Manufacturers industry median Gross Margin % is 48.54. Joyzyme Group's value of 58.62% is 20.8% above this industry median. Based on the distribution chart, Joyzyme Group ranks #252 out of 939 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Joyzyme Group has a GF Score™ of 40/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Joyzyme Group's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Joyzyme Group ranks #252 out of 939 companies for Gross Margin %. This puts Joyzyme Group in the upper half of its industry. The industry median Gross Margin % is 48.54. Joyzyme Group's value of 58.62% is 20.8% above this benchmark. Historically, Joyzyme Group's own Gross Margin % has ranged from 62.80 to 75.25 over the past decade. While the company's 10-year median is 67.16 vs. the industry median of 48.54, Joyzyme Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 939 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joyzyme Group's current Gross Margin % of 58.62% is 20.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Joyzyme Group and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joyzyme Group's current Gross Margin % is 58.62%, which is 13% below median its own 10-year median of 67.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joyzyme Group stock overvalued right now?
Based on GuruFocus' analysis, Joyzyme Group (HKSE:08622) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.17, compared to a current price of HK$0.17 — trading 2.9% below its estimated fair value. The current Gross Margin % is 58.62%, which is 13% below median its 10-year median of 67.16 and 20.8% above the Drug Manufacturers industry median of 48.54. Joyzyme Group's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Joyzyme Group (HKSE:08622), the current Gross Margin % is 58.62% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Joyzyme Group (HKSE:08622) Overvalued in 2026?
Based on GuruFocus' analysis, Joyzyme Group stock appears to be undervalued.
The current stock price of HK$0.17 is trading 2.9% below its estimated GF Value™ of HK$0.17.
GuruFocus considers Joyzyme Group to be Fairly Valued.
Key valuation signals for HKSE:08622:
Gross Margin %: 58.62% (13% below median its 10-year median of 67.16)
GF Value™: HK$0.17 vs. price of HK$0.17 (2.9% below fair value)
Industry Position: 20.8% above the Drug Manufacturers median (#252 of 939)
No single metric tells the full story. See the HKSE:08622 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo.16 Yinkui Road, 1-3 floor and 5th floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN
Joyzyme Group Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in research and development, manufacture, marketing, and sale of biological reagents and auxiliary reproductive supplies and equipment, and healthcare products and supplements in the People's Republic of China (the PRC). It operates in two segments: Biological reagents and auxiliary reproductive supplies and equipment, and Healthcare products and supplements. It generates the majority of its revenue from the biological reagents and auxiliary reproductive supplies and equipment segment. Geographically, it generates revenue from the PRC.
40GF Score
Get the complete analysis for HKSE:08622
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08622 has been successfully added to your 
